Previous 10 | Next 10 |
2024-02-03 05:35:00 ET Everybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that means you could win big each time this player reports positive news and makes progress toward its goals. Of course, ...
2024-02-02 10:44:53 ET More on Novavax Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript J.P. Morgan 42nd Annual Healthcare Conference Novavax: Do Not Expect A Turnaround In 2024 Novavax to cut 12% of globa...
2024-01-31 10:17:51 ET More on Novavax Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript J.P. Morgan 42nd Annual Healthcare Conference Novavax: Do Not Expect A Turnaround In 2024 Masking returns to some U.S...
2024-01-31 00:21:00 ET Summary Q4 marks the end of a difficult year for Russell 2000 earnings. Energy is no longer the 'top dog' from an earnings growth contribution perspective. Financials has the largest earnings weight for the second consecutive quarter. By Taji...
2024-01-29 08:15:00 ET Like many of the biotechs pursuing coronavirus vaccine development, Novavax (NASDAQ: NVAX) has seen better days. Its shares are down by 96% over the past three years, and the company's remaining shareholders face fading hopes for a spontaneous revival. Non...
2024-01-28 07:25:00 ET Novavax (NASDAQ: NVAX) shares have offered investors a roller coaster ride over the past few years. They soared more than 2,700% in early pandemic days as investors bet on the company's investigational vaccine -- then plummeted 98% from their peak as the vacci...
2024-01-23 09:13:00 ET Novavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a coronavirus vaccine to market. The company followed through on that -- but not as quickly as planned. Novavax's product launched more than a year af...
2024-01-15 14:21:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Following last year’s big rally, the stock market is off to a slow start in 2024. After two weeks the S&P 500 index is essentially flat. That’s not enough time to make a t...
2024-01-09 13:35:18 ET Novavax, Inc. (NVAX) JPMorgan 42nd Annual Healthcare Conference January 08, 2024, 08:15 PM ET Company Participants John Jacobs - President and CEO John Trizzino - Chief Commercial Officer & Chief Business Officer James Kelly - CFO F...
2024-01-04 13:51:02 ET More on BioNTech, Moderna, etc. Pfizer: If You Missed The Pandemic Entry, Here's Another Chance BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovatio...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...